Camlin Fine Sciences Statistics
Total Valuation
Camlin Fine Sciences has a market cap or net worth of INR 17.83 billion. The enterprise value is 23.78 billion.
Market Cap | 17.83B |
Enterprise Value | 23.78B |
Important Dates
The next estimated earnings date is Tuesday, November 5, 2024.
Earnings Date | Nov 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Camlin Fine Sciences has 167.50 million shares outstanding. The number of shares has decreased by -6.31% in one year.
Shares Outstanding | 167.50M |
Shares Change (YoY) | -6.31% |
Shares Change (QoQ) | +0.61% |
Owned by Insiders (%) | 20.38% |
Owned by Institutions (%) | 6.00% |
Float | 80.18M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 30.20 |
PS Ratio | 1.12 |
PB Ratio | 2.06 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -16.72 |
EV / Sales | 1.50 |
EV / EBITDA | 24.25 |
EV / EBIT | 137.40 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 79.70 |
Debt / EBITDA | 6.97 |
Debt / FCF | n/a |
Interest Coverage | 0.27 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 0.68% |
Revenue Per Employee | 25.47M |
Profits Per Employee | -2.28M |
Employee Count | 624 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.12% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -39.12% |
50-Day Moving Average | 108.46 |
200-Day Moving Average | 113.71 |
Relative Strength Index (RSI) | 49.78 |
Average Volume (20 Days) | 85,033 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Camlin Fine Sciences had revenue of INR 15.89 billion and -1.42 billion in losses. Loss per share was -8.49.
Revenue | 15.89B |
Gross Profit | 6.35B |
Operating Income | 173.07M |
Pretax Income | -1.39B |
Net Income | -1.42B |
EBITDA | 885.91M |
EBIT | 173.07M |
Loss Per Share | -8.49 |
Balance Sheet
The company has 802.55 million in cash and 6.83 billion in debt, giving a net cash position of -6.03 billion or -35.99 per share.
Cash & Cash Equivalents | 802.55M |
Total Debt | 6.83B |
Net Cash | -6.03B |
Net Cash Per Share | -35.99 |
Equity (Book Value) | 8.57B |
Book Value Per Share | 51.64 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 39.96%, with operating and profit margins of 1.09% and -8.95%.
Gross Margin | 39.96% |
Operating Margin | 1.09% |
Pretax Margin | -8.73% |
Profit Margin | -8.95% |
EBITDA Margin | 5.57% |
EBIT Margin | 1.09% |
FCF Margin | n/a |
Dividends & Yields
Camlin Fine Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 6.31% |
Shareholder Yield | 6.31% |
Earnings Yield | -7.98% |
FCF Yield | n/a |
Stock Splits
The last stock split was on September 4, 2014. It was a forward split with a ratio of 2.
Last Split Date | Sep 4, 2014 |
Split Type | Forward |
Split Ratio | 2 |